Cardlytics (NASDAQ:CDLX) Issues Earnings Results

Cardlytics (NASDAQ:CDLXGet Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18, Briefing.com reports. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The company had revenue of $67.06 million for the quarter, compared to analysts’ expectations of $57.77 million. During the same period in the prior year, the company posted ($0.26) EPS. Cardlytics’s revenue was down 15.1% compared to the same quarter last year. Cardlytics updated its Q4 2024 guidance to EPS.

Cardlytics Price Performance

Shares of NASDAQ CDLX traded up $0.30 during trading hours on Friday, reaching $4.37. 1,752,101 shares of the stock traded hands, compared to its average volume of 1,242,283. The company’s 50-day simple moving average is $3.69 and its two-hundred day simple moving average is $6.70. The company has a market capitalization of $217.80 million, a P/E ratio of -1.14 and a beta of 1.61. Cardlytics has a 52-week low of $2.89 and a 52-week high of $20.52. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 1.01.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CDLX. Northland Securities lowered Cardlytics from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $7.00 to $5.00 in a research note on Friday, August 16th. Lake Street Capital cut shares of Cardlytics from a “buy” rating to a “hold” rating and reduced their price objective for the company from $18.00 to $5.00 in a research note on Thursday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Thursday. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Finally, Northland Capmk cut shares of Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $6.92.

Check Out Our Latest Research Report on CDLX

Insider Buying and Selling at Cardlytics

In other Cardlytics news, Director Scott A. Hill acquired 40,000 shares of the stock in a transaction dated Monday, August 12th. The stock was purchased at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the acquisition, the director now owns 40,000 shares in the company, valued at $143,200. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Scott A. Hill acquired 40,000 shares of the stock in a transaction on Monday, August 12th. The stock was purchased at an average price of $3.58 per share, for a total transaction of $143,200.00. Following the completion of the transaction, the director now owns 40,000 shares of the company’s stock, valued at $143,200. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Amit Gupta sold 22,607 shares of Cardlytics stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the transaction, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,573 shares of company stock worth $151,612 over the last ninety days. Insiders own 4.40% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.